Uptick Newswire Hosts BioCorRx Inc’s CEO and CFO to Discuss Their Recent NIDA Grant for Their Naltrexone Implant for Opioid Use Disorder PHOENIX, Jan. 28, 2019 (GLOBE NEWSWIRE) -- The Uptick Newswire Stock Day Podcast welcomed BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment...

BioCorRx Inc.’s CEO Talks NIDA Grant Update and a Promising New Product with Uptick Newswire’s Stock Day Podcast PHOENIX, Oct. 23, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") is a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions. President,...

CORRECTION: CEO, Brady Granier, From BioCorRx® Inc. Discusses Upcoming FDA Meeting on “Stock Day” Podcast; Aims to Fight Opioid Crisis PHOENIX, Jan. 22, 2018 (GLOBE NEWSWIRE) -- The Uptick Newswire “Stock Day” podcast keeps investors up to date on the latest penny stock news by bringing transparency in the micro-cap side of the...

CEO, Brady Grainer, From BioCorRx®Inc. Paves Pathway Towards Possible FDA Approval on “Stock Day” Podcast; Aims to Fight Opioid Crisis PHOENIX, Jan. 22, 2018 (GLOBE NEWSWIRE) -- The Uptick Newswire “Stock Day” podcast keeps investors up to date on the latest penny stock news by bringing transparency in the micro-cap side of the...